Sign in
SuspendedNo phase

Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening

Key facts

Who runs it
Metabiomics Corp
Where
Carlsbad, United StatesSee the site
Trial code
Status
Suspended
People taking part
12,000 people, planned
Started
1 Mar 2026
Expected to end
1 Mar 2028
Type of study
Observational
Treatments tested
  • LifeKit Prevent Colorectal Neoplasia Test
  • FIT Test
Record updated
26 September 2025
Why it stopped
fundraising

Who can take part

Age
40 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • An individual must meet all of the criteria below to be eligible
  • Subject is ≥ 40 years of age at the time of enrollment
  • Subject presents for a screening colonoscopy per standard of care
  • Subject has no symptoms or signs that require immediate, or near term, referral for diagnostic or therapeutic colonoscopy
  • Subject is able and willing to sign informed consent

Who cannot take part

  • Subject has had a positive Cologuard, fecal occult blood test or FIT within the previous 2 years
  • Subject has undergone a colonoscopy within the previous 9 years
  • Subject has had overt rectal bleeding within the previous 30 days
  • Subject has a history of CRC or advanced precancerous lesions
  • Subject has a diagnosis or medical history of any of the following conditions:; Familial adenomatous polyposis (also referred to as "FAP", including attenuated FAP and Gardner's syndrome); Hereditary non-polyposis CRC syndrome (also referred to as "HNPCC" or "Lynch Syndrome"); Other hereditary cancer syndromes, including but are not limited to, Peutz-Jeghers Syndrome, MYH-Associated Polyposis (MAP), Turcot's (or Crail's) Syndrome, Cowden's Syndrome, Juvenile Polyposis, Neurofibromatosis, or Familial Hyperplastic Polyposis
  • Subject has a diagnosis or personal history of inflammatory bowel disease (IBD), including chronic ulcerative colitis or Crohn's disease
  • Subject has a diagnosis of Cronkhite-Canada Syndrome
  • Subject has any condition that in the opinion of the Investigator should preclude participation in the study
  • An individual meeting any of the below criteria is ineligible

Where in United States

  • Solvd HealthCarlsbad, United States

About the trial

What the trial wants to find out

The purpose of this study is to determine the sensitivity and specificity for LifeKit Prevent Colorectal Neoplasia Test for colorectal cancer (CRC) and for adenoma, including advanced adenoma.

Treatments tested

  • LifeKit Prevent Colorectal Neoplasia Test
  • FIT Test

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Subject Enrollment and Specimen Collection Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for Colorectal Cancer Screening
Record updated
26 September 2025